Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.49 |
| ▸ | DAO | P14920 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | ABL1 | P00519 | 1/20 | 0.45 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxiniacic Acid SCHEMBL29766756 | 1.00 | MEN1 (1.00) | MEN1KMT2AGPR84DAOTSHR | |
| SCHEMBL10920085 | 0.83 | MEN1 (0.71) | MEN1KMT2AGPR84L3MBTL1ABL1 | |
| SCHEMBL10899428 | 0.83 | MEN1 (0.71) | MEN1KMT2AGPR84L3MBTL1ABL1 | |
| Oxiniacic Acid SCHEMBL29026495 | 0.81 | KMT2A (0.66) | MEN1KMT2AGPR84DAOTSHR | |
| SCHEMBL128526 | 0.81 | MEN1 (0.68) | MEN1KMT2AGPR84TSHRL3MBTL1 | |
| SCHEMBL212234 | 0.81 | MEN1 (0.68) | MEN1KMT2AGPR84L3MBTL1ABL1 | |
| SCHEMBL29618255 | 0.81 | MEN1 (0.68) | MEN1KMT2AGPR84TSHRL3MBTL1 | |
| SCHEMBL2772084 | 0.81 | MEN1 (0.68) | MEN1KMT2AGPR84TSHRL3MBTL1 | |
| SCHEMBL9083270 | 0.81 | MEN1 (0.68) | MEN1KMT2AGPR84L3MBTL1ABL1 | |
| Hydrochloric Acid SCHEMBL11050103 | 0.79 | MEN1 (0.66) | MEN1KMT2AGPR84TSHRL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1007 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746844-A1 | PERSONAL CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2026-05-27 | — | — | EP | claimed |
| US-20250161200-A1 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | THE BOOTS COMPANY PLC (GB) | 2025-05-22 | — | — | US | claimed |
| US-20250161201-A1 | COSMETIC COMPOSITION | THE BOOTS COMPANY PLC (GB) | 2025-05-22 | — | — | US | claimed |
| WO-2025043091-A1 | PERSONAL CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2025-02-27 | — | — | WO | claimed |
| EP-4479145-A1 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | The Boots Company PLC (GB) | 2024-12-25 | — | — | EP | claimed |
| EP-4479146-A1 | COSMETIC COMPOSITION | The Boots Company PLC (GB) | 2024-12-25 | — | — | EP | claimed |
| WO-2023156070-A1 | COSMETIC COMPOSITION | THE BOOTS COMPANY PLC (GB) | 2023-08-24 | — | — | WO | claimed |
| WO-2023156069-A1 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | THE BOOTS COMPANY PLC (GB) | 2023-08-24 | — | — | WO | claimed |
| US-20230157939-A1 | PERSONAL CARE COMPOSITIONS WITH ENHANCED SOLUBILITY ACTIVES | CONOPCO, INC., D/B/A UNILEVER (US) | 2023-05-25 | — | — | US | claimed |
| US-20230101362-A1 | RNA STABILIZATION | TEAM MEDICAL LLC | 2023-03-30 | — | — | US | claimed |
| WO-2005023305-A2 | MODULATING CELL ACTIVITY BY USING AN AGENT THAT REDUCES THE LEVEL OF CHOLESTEROL WITHIN A CELL | INPHARMATICA LIMITED (GB) | 2005-03-17 | — | — | WO | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| WO-1998022114-A1 | A METHOD FOR PROMOTING TISSUE REPAIR | DUMEX-ALPHARMA A/S (DK) | 1998-05-28 | — | — | WO | claimed |
| US-5472687-A | A water in oil or oil in water emulsion for treating hair loss ; free of hypotensive agent, side-effect reduction | PROCTOR PETER H (US) | 1995-12-05 | — | — | US | claimed |
| US-5179097-A | Salts of non-steroidal anti-inflammatory carboxylic acids and anti-lipidemic carboxylic acids | ANGRES ISAAC A (US) | 1993-01-12 | — | — | US | claimed |
| US-4866067-A | TREATMENT OF HAIR LOSS OF PATHOLOGIC FORMS; WATER SOLUBLE SALT OF MINOXIDIL | Ricerche De Schiena s.n.c del Dr. Michele Giuseppe Di Schiena & C. (IT) | 1989-09-12 | — | — | US | claimed |
| US-4058534-A | Therapeutically effective nicotinates and N-oxide nicotinates of aliphatic amines | SOLCO BASEL AG (CH) | 1977-11-15 | — | — | US | claimed |
| US-4000047-A | PYRIDINE OR QUINOLINE COMPOUND BRIGHTENERS | LEA-RONAL, INC. (US) | 1976-12-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250161200-A1 | COSMETIC COMPOSITION COMPRISING EXTRACT OF OPHIOPOGON JAPONICUS AND AT LEAST ONE CERAMIDE | SGMS2, SGMS1, CERS2 | MEN1 2323/4885KMT2A 3447/4885GPR84 1902/4885 |
| US-20230157939-A1 | PERSONAL CARE COMPOSITIONS WITH ENHANCED SOLUBILITY ACTIVES | CUTA, CBS, SLC7A11 | MEN1 3851/4885KMT2A 2100/4885GPR84 3347/4885 |
| US-20250161201-A1 | COSMETIC COMPOSITION | CYP19A1, SHBG, HSD17B11 | MEN1 2548/4885KMT2A 3132/4885GPR84 2789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.